Zika virus infection (ZVI) is a great concern for human health because it frequently causes fetal anomalies. Little is known about pathophysiology of ZVI because it has been regarded as a mild, no life-threatening infection. However, the latest endemic in 
| INTRODUCTION
On
| VIROLOGY
Zika virus is a mosquito-borne flavivirus, related to the dengue, yel- 
| EPIDEMIOLOGY
The Zika virus was first isolated in 1947 from rhesus monkeys captured in the Zika forest of Uganda during yellow fever research by the Rockefeller Institute. 
| SYMPTOMS
The incubation period for ZVI averages 6 days, 5 and the total duration of illness from onset to recovery is 1-2 weeks. Symptoms of ZVI are similar to those of dengue and chikungunya. The reported frequencies of the most common signs and symptoms are as follows: exanthema (98%), headache (67%), fever (67%), arthralgia (58%), myalgia (49%), conjunctivitis (39%), and joint swelling (23%). 6 Exanthema is the most common symptom and is typically characterized as a maculopapular rash with pruritus. The frequency of pruritus and itching is 56%-94% [6] [7] [8] Fever is uncommon and estimated to occur in only 28%-36% of cases 7, 8 In febrile cases, body temperatures do not exceed 38.0°C
and fever is of short duration. While conjunctivitis is less frequent compared with other signs and symptoms, it is the most specific sign of Zika virus infection. 7 Gastrointestinal and respiratory symptoms are less frequent. The overall severity of ZVI is less than the severity of dengue and chikungunya. Deaths associated with ZVI are rare.
However, immunocompromised individuals and patients with preexisting comorbidities are at increased risk for mortality. 
| NEUROLOGICAL COMPLICATIONS OF ZIKA VIRUS INFECTION

| TRANSMISSION
Zika virus has been detected in blood, urine, saliva, semen, amniotic fluid, and neural tissues. The virus is mainly transmitted by mosquito bites, sexual activity, 22 and maternal-fetal routes. Blood transfusions, organ and tissue transplants, and other medical interventions including reproductive treatment also possibly transmit the Zika virus. When anti-Zika virus antibody is positive or equivocal, the most important is whether the patient is pregnant or not because prolonged viremia has been reported in pregnant women. 24 Therefore, if the patient is pregnant, rRT-PCR should be performed first. If the patient is not pregnant, the diagnosis should be confirmed by detecting Zika virus-specific neutralizing antibodies.
| DIAGNOSIS
Due to high cross-reactivity of IgM antibodies to other flaviviruses, testing for dengue and chikungunya IgM should be performed simultaneously. When any sample is positive or equivocal, results should be confirmed by rRT-PCR or tests for Zika-specific neutralizing antibodies.
Practitioners needing assistance with diagnosis of ZVI should consult "Guidance for U.S. Laboratories Testing for Zika Virus Infection," available at the CDC's Web site. 25 The algorithms in this guide are especially helpful for diagnosis.
| PREGNANCY
Zika virus infection is of great concern especially during pregnancy because it causes microcephaly and other congenital abnormalities.
Generally, pregnant women are believed to be in an immunosuppressed state, but pregnancy is not a risk factor for a severe clinical course of ZVI. 7 The symptoms and course of infection of Zika in pregnant women are identical to those in non-pregnant individuals.
Risk factors for vertical Zika virus transmission are still under investigation, but many researchers agree that viral exposure during early pregnancy is important, similar to exposure to cytomegalovirus and rubella. 26 In a prospective Brazilian study, vertical Zika virus transmission associated with microcephaly and other neural complications was observed only in patients who presented with a skin rash in the first or second trimester. 7 In patients who presented with a skin rash in the third trimester, only non-specific neonatal neurological anomalies such as intrauterine growth restriction (IUGR) and anhydramnios were observed. In another study conducted in Colombia, no neonatal neurological anomalies were reported in 616 third-trimester patients with ZVI. 27 This critical period of neuronal infection in the first and second trimesters must be confirmed via additional epidemiological studies.
Zika virus infection transmission through sexual activity has also recently been reported. Zika virus is highly concentrated in semen (over 100 000 times higher than in serum) 28 and is transmitted to female partners through vaginal, anal, and oral intercourses. Female-to-male transmission is less frequent than male-to-female transmission. 29 Even asymptomatic male patients can transmit Zika virus to female partners. 30 Based on epidemiological data, the CDC recommends 6 months of safe sex (routine condom use) or avoidance of sexual activity for male patients and 8 weeks for female patients who develop ZVI. Neural stem cells generated from human iPS cells are also susceptible to Zika virus and fall into apoptosis. 34 In autopsies of human neonatal microcephaly cases, Zika virus was detected only in the tissues of the central nervous system. 35 Taken together, these observations suggest that the Zika virus invades the placenta through the maternal circulation and, due to its neurotropic nature, is transported to the central nervous system. and TIM-4 in virus uptake has also been suggested. 41 Susceptibility of A549 cells, which express AXL and TIM-1, was blocked by anti-AXL antibody in vitro. Conversely, susceptibility of A549 cells was rarely blocked by anti-TIM-1 antibodies. 41 Human skin fibroblasts express AXL and do not express TIM-1. 41 Moreover, AXL is expressed in radial glial cells, astrocytes, endothelial cells, and microglia in the immature brain cortex of humans. Progenitor cells in immature retinas also express AXL. 42 These data suggest that AXL is associated with the invasion of the central nervous system by Zika virus. Table 1 . The functional morphology of Zika virus has been recently elucidated using cryo-electron microscopy. 43 The Zika virus shares a common structure with other flaviviruses except for the 180 virus-specific envelope glycoproteins that make up the icosahedral shell. Ten or less amino acid motifs surrounding the Asn 154 glycosylation in each glycoprotein are Zika-specific and might contribute to the virus's pathogenicity. The Zika virus employs the glycosylation site to attach to host cells, and these differences might influence the efficiency of viral entry and tissue specificity.
The NS2B-NS3 protease is another candidate for viral virulence.
Although the NS2B-NS3 protease is expressed by other flaviviruses such as the dengue and West Nile viruses, its enzymatic activity in Zika is much higher. 44 Because type I IFNs are inactivated by viral proteases, high NS2B-NS3 protease activity might suppress the innate host immune response against viral infection. Interestingly, inhibition of the dengue virus 2-specific NS2B-NS3 protease by boric acid suppresses viral replication of dengue viruses. 45 In this sense, natural or synthetic substances with antiprotease activity may be resources for novel therapeutic strategies. It is unclear that the limited antibodies transfer is responsible for severe ZVI.
| CONCLUSIONS
Zika virus-related central nervous system complications, including microcephaly, are a central public health issue, especially for women of child-bearing age. Although concentrated efforts are being made to design a vaccine against the Zika virus, 51, 52 so far it has not been successful. Other efforts are focused on the invention of antiviral medications effective against the Zika virus. In HIV/AIDS and syphilis, in utero infections are almost completely controlled by effective chemotherapy. 53 We can expect new antiviral medicines to control ZVI in utero. To get this Holy Grail, it will require a greater understanding of the pathophysiology of Zika virus replication and the mechanisms of cross-placental transmission.
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